ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK 949858 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 102.9M shares as of Aug 11, 2026 (10-Q).⊙
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Warrant | 49.5M | $3.51 | — | — |
| Warrants Issued In April Two Thousand Twenty Six | 49.5M | $3.51 | — | — |
| Warrants Issued In June Two Thousand Twenty Five | 16.3M | $3 | — | — |
| Warrants Issued In November Two Thousand Twenty Two | 4.1M | $4.5 | — | — |
| Warrants Issued In August Two Thousand Twenty | 142,857 | $0.001 | — | — |
| Pre Funded Warrants | 100,500 | $0.001 | — | — |
| Pre Funded Warrants Issued In April Two Thousand Twenty Six | 100,500 | $0.001 | — | — |
| June Twenty Twenty Five Financing | 7,000 | $3 | — | — |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 11, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 1.6M underlying shares, as reported Jun 30, 2014 (10-Q).
Reported exercise price: $4 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $3,000 as of Sep 30, 2017.
Rough fully diluted estimate: 104.5M = 102.9M O/S + 1.6M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| Two Thousand Twenty Four Silicon Valley Bank Convertible Debt | $15.0M | $14.9M | not tagged | — | — |
| New Convertible Term Loan | $15.0M | $14.9M | not tagged | — | — |
| Contingent Convertible Debt Agreement | $5.0M | — | $7 | — | ~714,286 sh |
| Convertible Debt Agreement | $5.0M | — | not tagged | 7% | — |
If every note above converted at its tagged price: ~714,286 new shares on 102.9M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.
Notes exactly as the company dimensioned them in its 10-Q filed Aug 11, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 102.9M | Aug 11, 2026 |
| + Warrant (if exercised) | 49.5M | Apr 15, 2026 |
| + Warrants Issued In April Two Thousand Twenty Six (if exercised) | 49.5M | Jun 30, 2026 |
| + Warrants Issued In June Two Thousand Twenty Five (if exercised) | 16.3M | Jun 30, 2026 |
| + Warrants Issued In November Two Thousand Twenty Two (if exercised) | 4.1M | Jun 30, 2026 |
| + Warrants Issued In August Two Thousand Twenty (if exercised) | 142,857 | Jun 30, 2026 |
| + Pre Funded Warrants (if exercised) | 100,500 | Apr 15, 2026 |
| + Pre Funded Warrants Issued In April Two Thousand Twenty Six (if exercised) | 100,500 | Jun 30, 2026 |
| + June Twenty Twenty Five Financing (if exercised) | 7,000 | Jun 30, 2026 |
| + Contingent Convertible Debt Agreement (if fully converted) | 714,286 | Dec 31, 2025 |
| Fully diluted estimate | 223.4M | +117.1% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $800.1Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 2 executed · 2 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full ACHV workspace
Free to use. No account, no card.